|
P 004292 / Paratek (0 Trials) |
P 1055 / Parion Sciences (0 Trials) |
P 2202 / Eli Lilly, Piramal Phytocare (0 Trials) |
P 979 / Piramal Phytocare (0 Trials) |
P-001 / NB Health Lab (0 Trials) |
P-015 / NB Health Lab (0 Trials) |
P-11187 / Piramal Phytocare (0 Trials) |
P-321 / Parion Sciences (0 Trials) |
P-500 / Pathos (0 Trials) |
P-BCMA-101 / Poseida Therap (2 Trials) |
P-BCMACD19-ALLO1 / Poseida Therap, Roche (0 Trials) |
P-CD70-ALLO1 / Poseida Therap, Roche (0 Trials) |
P-ckit-ALLO1 / Poseida Therap (0 Trials) |
P-FVIII-101 / Poseida Therap (0 Trials) |
P-MUC1C-101 / Poseida Therap (0 Trials) |
P-MUC1C-ALLO1 / Poseida Therap (0 Trials) |
P-PSMA-101 / Poseida Therap (1 Trials) |
P-PSMA-ALLO1 / Poseida Therap (0 Trials) |
P-selectin glycoprotein ligand (PGSL) and Human IgG1 (YSPSL) / Y's Therap (0 Trials) |
P. gingivalis/POD OH-CRC / CSL Behring (0 Trials) |
p.DOM-WT1-126 DNA vaccine / Inovio (0 Trials) |
P005 / NB Health Lab (0 Trials) |
P007 / NB Health Lab (0 Trials) |
P013 / NB Health Lab (0 Trials) |
P013 (pertuzumab biosimilar) / CinnaGen (0 Trials) |
P11 / Protheragen (0 Trials) |
P1201-07 / Piramal Phytocare (0 Trials) |
P1736 / Piramal Phytocare (0 Trials) |
P2-003 / Luye Group (0 Trials) |
P2-004 / Luye Group (0 Trials) |
P218 / Medicines for Malaria Venture (0 Trials) |
P22077 / Progenra (0 Trials) |
P23H RHO / Precision BioSci (0 Trials) |
P2745 / Piramal Phytocare (0 Trials) |
P2B002 / Pharma Two B (0 Trials) |
P2B003 / Pharma Two B (0 Trials) |
P2X4 Antagonist / Bayer (0 Trials) |
P30-EPS / Duke University, National Cancer Institute (0 Trials) |
P300-CBP transcription factor inhibitor / Acylin Therap (0 Trials) |
P306 / Fox Chase Cancer Center (0 Trials) |
P5091 / Progenra (0 Trials) |
p53/KRAS/EGFR targeted NK cell therapy / Athenex (0 Trials) |
p53MVA / Tara I-O (2 Trials) |
P7435 / Piramal Phytocare (0 Trials) |
P75NEURO / Protheragen (0 Trials) |
P9R / University of Hong Kong (0 Trials) |
PA1010 / Palo Alto Pharma (0 Trials) |
PA83-FhCMB / iBio (0 Trials) |
PAb001-ADC / Peptron (0 Trials) |
PAb001-Car-T / Peptron (0 Trials) |
Pabparna (BB-301) / Benitec BioPharma (0 Trials) |
PAC-1 / Vanquish Oncology (2 Trials) |
PAC-MAN / Stanford University, DNARx (0 Trials) |
pacanalotamab (AMG 420) / Amgen (1 Trials) |
Pacis (bladder cancer vaccine) / GSK (0 Trials) |
Paclical (micellar paclitaxel) / Vivesto, HLB Bio Group (0 Trials) |
paclitaxel / Generic mfg. (1388 Trials) |
paclitaxel (QR 207) / Qrono (0 Trials) |
paclitaxel micelle formulation (NK-105) / NANO MRNA, Nippon Kayaku (0 Trials) |
paclitaxel submicron particle (SOR007) / DFB Pharma, NanOlogy (0 Trials) |
paclitaxel sustained release (PTM-101) / PanTher (0 Trials) |
paclitaxel trevatide (ANG1005) / Angiochem (2 Trials) |
paclitaxel+novel excipient (TYN-21) / BW Therap (0 Trials) |
paclitaxel/NLPD (SG102) / SevenGenes (0 Trials) |
pacmilimab (CX-072) / CytomX (2 Trials) |
PACTN / PersImmune (0 Trials) |
Padcev (enfortumab vedotin-ejfv) / Astellas, Pfizer (41 Trials) |
PADciclo (ciclosporin ophthalmic) / MC2 Therap, Moorfields Eye Hospital (0 Trials) |
padnarsertib (KPT-9274) / Karyopharm (2 Trials) |
padsevonil (UCB0942) / UCB (0 Trials) |
palazestrant (OP-1250) / Olema Pharma (0 Trials) |
Palexia RP (tapentadol extended release) / Assertio, J&J, Grunenthal, Collegium Pharma (4 Trials) |
Palforzia (peanut (Arachis hypogaea) allergen powder-dnfp) / Nestle (6 Trials) |
PALI-2108 / Palisade Bio (0 Trials) |
paliperidone depot injection / Mapi Pharma (0 Trials) |
paliperidone extended release / Generic mfg. (5 Trials) |
paliperidone palmitate ER (LY03010) / Luye Group (0 Trials) |
Paliperidone-ISM (paliperidone in situ microparticle) / ROVI Pharmaceuticals Laboratories (0 Trials) |
palivizumab biosimilar / BioXpress Therap (0 Trials) |
palivizumab biosimilar / iBio (0 Trials) |
palivizumab biosimilar / Utrecht Centre of Excellence for Affordable Biotherapeutics (0 Trials) |
palivizumab biosimilar / NeuClone, Serum Institute of India (0 Trials) |
palmatine / LKT Labs (0 Trials) |
palonosetron intravenous / Generic mfg. (11 Trials) |
paltimatrectinib (PBI-200) / Biohaven (0 Trials) |
paltusotine (CRN00808) / Crinetics (0 Trials) |
palucorcel (CNTO 2476) / J&J (0 Trials) |
Paludrine (proguanil) / Alliance (1 Trials) |
palupiprant (AN0025) / Eisai, Adlai Nortye (2 Trials) |
Palynziq (pegvaliase-pqpz) / BioMarin (2 Trials) |
pamapimod (RO4402257) / Roche (1 Trials) |
pamapimod/pioglitazone (KIN001) / Kinarus (0 Trials) |
pamidronate disodium / Generic mfg. (5 Trials) |
pamrevlumab (FG-3019) / FibroGen (1 Trials) |
pamufetinib (TAS-115) / Otsuka (1 Trials) |
PAN-90806 / PanOptica (0 Trials) |
PAN004 / Pantherna Therap (0 Trials) |
PAN006 / Pantherna Therap (0 Trials) |
PAN007 / Pantherna Therap (0 Trials) |
Panaecin (gallium citrate) / Aridis (0 Trials) |
Panaphix (sodium metaarsenite) / Komipharm (0 Trials) |
Panblok (influenza vaccine) / Sanofi (0 Trials) |
Panblok H7/MF59 influenza vaccine / Sanofi (0 Trials) |
PanChol (live attenuated oral cholera vaccine) / Brigham and Womens Hospital (0 Trials) |
pancreatic cancer vaccine / CPL Biologicals, Novavax (0 Trials) |
pancrelipase (NMK-150) / AbbVie (0 Trials) |
PanCytoVir (probenecid) / TrippBio (0 Trials) |
PANDA-VAC / UNC Lineberger Comprehensive Cancer Center (0 Trials) |
Pandel (hydrocortisone probutate) / Novartis (0 Trials) |
Pandemic influenza vaccine H5N1 AstraZeneca (pandemic influenza vaccine (H5N1) (live attenuated, nasal)) / AstraZeneca (0 Trials) |
Pandemic Influenza Vaccine H5N1 Baxter AG (pandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture)) / Baxter Healthcare (0 Trials) |
Pandyflu (inactivated H1N1 split virion vaccine) / Panacea Biotec (0 Trials) |
Panenza (influenza A (H1N1) 2009 monovalent vaccine) / Sanofi (0 Trials) |
PanFlu (influenza H5N1 vaccine) / Sinovac (0 Trials) |
PANFLU.1 (influenza A H1N1 influenza virus split vaccine) / Sinovac (0 Trials) |
Panglobulin NF (intravenous normal human immunoglobulin) / CSL Behring (0 Trials) |
Panhematin (hemin) / Lundbeck, Recordati (1 Trials) |
PANHPVAX / German Cancer Research Center (0 Trials) |
PankoMab-GEX (gatipotuzumab) / Glycotope (0 Trials) |
panobinostat (MTX110) / Biodexa Pharma (3 Trials) |
PanOxyl PM Overnight Spot Patches (benzoyl peroxide) / Crown Labs (0 Trials) |
Panretin (alitretinoin topical) / Eisai (0 Trials) |
Panrvlysin (genetically engineered oncolytic virus therapy) / CZ BioMed (0 Trials) |
pantoprazole / Generic mfg. (31 Trials) |
panulisib (P7170) / Piramal Phytocare (0 Trials) |
Panvac-VF (falimarev/inalimarev) / Bavarian Nordic (3 Trials) |
Panvax (influenza A (H1N1) 2009 monovalent vaccine) / CSL Behring (0 Trials) |
Panzem (2-methoxyestradiol) / CASI (0 Trials) |
Panzyga (immune globulin intravenous, human-ifas) / Octapharma, Pfizer (2 Trials) |
PAP CAR-T / Innovative Cellular Therapeutics (0 Trials) |
papaverine / Generic mfg. (0 Trials) |
papiliximab / Shaperon (0 Trials) |
Papitrol (tirvalimogene teraplasmid) / Genexine, National OncoVenture (2 Trials) |
paquinimod (ABR-215757) / Active Biotech (0 Trials) |
PAR-2 / Sawai Pharma (0 Trials) |
para-toluenesulfonamide (PTS100) / Gongwin Biopharm (0 Trials) |
paracetamol / Generic mfg. (384 Trials) |
paracetamol suspension / Generic mfg. (0 Trials) |
paracetamol Uniflash / Unither (0 Trials) |
paracetamol/caffeine / Generic mfg. (0 Trials) |
paracetamol/chlorpheniramine maleate/phenylepherine Hcl/caffeine / Generic mfg. (0 Trials) |
Parcoten (paracetamol/codeine phosphate) / Neurelis (0 Trials) |
pardoprunox (SLV-308) / AbbVie (1 Trials) |
parentide (DD04107) / BCN Peptides, Lubrizol (0 Trials) |
Pargevin (pargeverine) / AC Farma (0 Trials) |
Pargevin Compound (pargeverine/lysine clonixinate) / AC Farma (0 Trials) |
paricalcitol / Generic mfg. (31 Trials) |
paridiprubart (EB07) / Edesa Biotech, Light Chain Biosci (0 Trials) |
parimifasor (LYC-30937 EC) / BMS (0 Trials) |
paritaprevir/ritonavir (ABT-450/r) / AbbVie (1 Trials) |
Parkin activator / Vincere Biosci (0 Trials) |
Parkinsan (budipine) / Lundbeck, Takeda (1 Trials) |
Parkinson's disease therapeutic / Amgen (0 Trials) |
Parkinson's disease therapeutic / AgoneX Biopharma (0 Trials) |
Parkinson's disease therapeutic / C4X Discovery (0 Trials) |
Parkinson's disease therapeutic / Canvax (0 Trials) |
Parkinson’s Disease cell therapy / Innervace (0 Trials) |
Parmodia (pemafibrate) / Kowa (5 Trials) |
parogrelil (INDI 702) / Taisho (0 Trials) |
paroxetine / Generic mfg. (44 Trials) |
paroxetine extended release / Generic mfg. (3 Trials) |
paroxetine mesylate / Generic mfg. (0 Trials) |
PARP inhibitors / Rocket Pharma (0 Trials) |
PARP10 inhibitor / Ribon Therap (0 Trials) |
PARP11 inhibitor / Ribon Therap (0 Trials) |
PARP12 inhibitor / Ribon Therap (0 Trials) |
PARP15 inhibitor / Ribon Therap (0 Trials) |
PARP16 inhibitor / Ribon Therap (0 Trials) |
PARP3 inhibitor / Ribon Therap (0 Trials) |
PARP4 inhibitor / Ribon Therap (0 Trials) |
PARP6 inhibitor / Ribon Therap (0 Trials) |
PARP8 inhibitor / Ribon Therap (0 Trials) |
PARP9 inhibitor / Ribon Therap (0 Trials) |
Parsabiv (etelcalcetide) / Amgen (6 Trials) |
parsaclisib (INCB50465) / Incyte (27 Trials) |
parsatuzumab (RG7414) / Roche (0 Trials) |
Partruvix (pamiparib) / EMD Serono (17 Trials) |
ParvOryx (parvovirus H-1) / Oryx (0 Trials) |
PAS-003 / Pasithea (0 Trials) |
PAS-004 / Pasithea (1 Trials) |
PAS-393 / Pascal Biosci (0 Trials) |
PAS-403 / Pascal Biosci (0 Trials) |
PAS-IL-1Ra / XL-protein (0 Trials) |
pasotuxizumab (BAY2010112) / Amgen, Bayer (0 Trials) |
pasylated uricase (HZN-007) / XL-protein, Amgen (0 Trials) |
PAT-101 / Pasithea (0 Trials) |
PAT-102 / Pasithea (0 Trials) |
PAT-DX1 / Patrys (0 Trials) |
PAT-LM1 / Patrys (0 Trials) |
PAT-SC1 / Patrys (0 Trials) |
PAT-SM6 / Patrys (0 Trials) |
pateclizumab (RG7416) / Roche (0 Trials) |
pathogen reduced SARS-CoV-2 convalescent plasma / Vanderbilt University Medical Center (0 Trials) |
patidegib topical (IPI-926 topical) / Bridge Biotherap, LEO Pharma (0 Trials) |
Patria (Recombinant NDV Vectored Vaccine for SARS-CoV-2) / National Autonomous University of Mexico, Avimex, Mexican Social Security Institute (0 Trials) |
patritumab (U3-1287) / Amgen, Daiichi Sankyo (1 Trials) |
patritumab deruxtecan (U3-1402) / Daiichi Sankyo, Merck (MSD) (8 Trials) |
patupilone (EPO 906) / Novartis (3 Trials) |
Pavacol-D (pholcodine) / Alliance (0 Trials) |
Pavblu (aflibercept-ayyh) / Amgen (0 Trials) |
|